Point72 Asset Management, L.P. - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q2 2023$1,590,662
-87.5%
25,121
-89.3%
0.01%
-87.2%
Q1 2023$12,678,085
+23.4%
234,129
+20.6%
0.04%
+11.4%
Q4 2022$10,274,524
-66.3%
194,152
-70.4%
0.04%
-71.3%
Q3 2022$30,514,000
+114.0%
655,800
+18.0%
0.12%
+67.1%
Q3 2020$14,258,000
+240.9%
555,643
-0.8%
0.07%
+180.8%
Q3 2019$4,182,000
+243.3%
559,900
+459.9%
0.03%
+333.3%
Q1 2019$1,218,000
-64.4%
100,000
-66.7%
0.01%
-64.7%
Q4 2018$3,421,000
-75.2%
300,352
-52.7%
0.02%
-70.2%
Q3 2018$13,768,000
+310.4%
634,466
+234.2%
0.06%
+338.5%
Q2 2018$3,355,000
-30.9%
189,857
-17.6%
0.01%
-35.0%
Q1 2018$4,852,000
-25.5%
230,494
-48.8%
0.02%
-28.6%
Q4 2017$6,516,000
+58.4%
450,000
+72.6%
0.03%
+55.6%
Q3 2017$4,114,000
+76.1%
260,700
+70.1%
0.02%
+12.5%
Q3 2016$2,336,000
-64.5%
153,300
-9.5%
0.02%
-64.4%
Q2 2016$6,572,000
+2.5%
169,300
-26.6%
0.04%
-8.2%
Q1 2016$6,411,000
-27.4%
230,600
+40.4%
0.05%
-32.9%
Q4 2015$8,832,000
+807.7%
164,200
+575.7%
0.07%
+812.5%
Q3 2015$973,000
-73.3%
24,300
-78.7%
0.01%
-68.0%
Q2 2015$3,645,000
+69.9%
114,100
+27.0%
0.02%
+66.7%
Q1 2015$2,145,00089,8230.02%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders